Management of recurrent brain metastasis after radiosurgery

Progress in Neurological Surgery

Volumn 25, Issue , 2012, Pages 273-286

  Stockham, Abigail L ^a   Suh, John H ^a   Chao, Samuel T ^a   Barnett, Gene H ^a  

^a TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN TUMOR; HUMAN; METASTASIS; METHODOLOGY; RADIOSURGERY; REVIEW; SALVAGE THERAPY; TUMOR RECURRENCE;

BRAIN NEOPLASMS; HUMANS; NEOPLASM RECURRENCE, LOCAL; RADIOSURGERY; SALVAGE THERAPY;

EID: 84958655571     PISSN: 00796492     EISSN: 16623924     Source Type: Book Series    
DOI: 10.1159/000331200     Document Type: Article

References (37)

1. Loeffler JS, Kooy HM, Wen PY, Fine HA, Cheng C W, Mannarino EG, Tsai JS, Alexander E 3rd: The treatment of recurrent brain metastases with ste-reotactic radiosurgery. J Clin Oncol 1990;8:576.
2. Suh JH: Stereotactic radiosurgery for the management of brain metastases. N Engl J Med 2010;362: 1119.
3. Andrews D W, Scott CB, Sperduto P W, Flanders AE, Gaspar LE, Schell MC, Werner-Wasik M, Demas W, Ryu J, Bahary J P, Souhami L, Rotman M, Mehta MP, Curran WJ Jr: Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 2004;22:1665.
4. Aoyama H, Tago M, Kato N, Toyoda T, Kenjyo M, Hirota S, Shioura H, Inomata T, Kunieda E, Hayakawa K, Nakagawa K, Kobashi G, Shirato H: Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosur-gery alone. Int J Radiat Oncol Biol Phys 2007;68: 1388.
5. Chang EL, Wefel JS, Hess KR, Allen PK, Lang FF, Kornguth DG, Arbuckle RB, Swint JM, Shiu AS, Maor MH, Meyers CA: Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 2009;10:1037.
6. Chen JC, Petrovich Z, Giannotta SL, Yu C, Apuzzo ML: Radiosurgical salvage therapy for patients presenting with recurrence of metastatic disease to the brain. Neurosurgery 2000;46:860.
7. Aoyama H, Shirato H, Tago M, Nakagawa K, Toyoda T, Hatano K, Kenjyo M, Oya N, Hirota S, Shioura H, Kunieda E, Inomata T, Hayakawa K, Katoh N, Kobashi G: Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 2006;295:2483.
8. Regine WF, Huhn JL, Patchell RA, St Clair WH, Strottmann J, Meigooni A, Sanders M, Young AB: Risk of symptomatic brain tumor recurrence and neurologic deficit after radiosurgery alone in patients with newly diagnosed brain metastases: results and implications. Int J Radiat Oncol Biol Phys 2002;52:333.
9. Jain R, Narang J, Sundgren PM, Hearshen D, Saksena S, Rock J P, Gutierrez J, Mikkelsen T: Treatment induced necrosis versus recurrent/progressing brain tumor: going beyond the boundaries of conventional morphologic imaging. J Neurooncol 2010;100:17-29.
10. Dequesada IM, Quisling RG, Yachnis A, Friedman WA: Can standard magnetic resonance imaging reliably distinguish recurrent tumor from radiation necrosis after radiosurgery for brain metastases? A radiographic-pathological study. Neurosurgery 2008;63:898.
11. Kano H, Kondziolka D, Lobato-Polo J, Zorro O, Flickinger JC, Lunsford LD: T1/T2 matching to differentiate tumor growth from radiation effects after stereotactic radiosurgery. Neurosurgery 2010;66: 486.
12. Chao ST, Suh JH, Raja S, Lee SY, Barnett G: The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery. Int J Cancer 2001;96:191.
13. Hoefnagels F W, Lagerwaard FJ, Sanchez E, Haasbeek CJ, Knol DL, Slotman BJ, Vandertop WP: Radiological progression of cerebral metastases after radiosurgery: assessment of perfusion MRI for differentiating between necrosis and recurrence. J Neurol 2009;256:878.
14. Kimura T, Sako K, Tohyama Y, Aizawa S, Yoshida H, Aburano T, Tanaka K, Tanaka T: Diagnosis and treatment of progressive space-occupying radiation necrosis following stereotactic radiosurgery for brain metastasis: value of proton magnetic resonance spectroscopy. Acta Neurochir (Wien) 2003; 145:557.
15. Levin VA, Bidaut L, Hou P, Kumar AJ, Wefel JS, Bekele BN, Prabhu S, Loghin M, Gilbert MR, Jackson EF: Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system. Int J Radiat Oncol Biol Phys 2011;79:1487-1495.
16. Truong MT, St Clair EG, Donahue BR, Rush SC, Miller DC, Formenti SC, Knopp EA, Han K, Golfinos JG: Results of surgical resection for progression of brain metastases previously treated by gamma knife radiosurgery. Neurosurgery 2006;59: 86.
17. Shaw E, Scott C, Souhami L, Dinapoli R, Kline R, Loeffler J, Farnan N: Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys 2000;47:291.
18. Veninga T, Langendijk HA, Slotman BJ, Rutten EH, van der Kogel AJ, Prick MJ, Keyser A, van der Maazen RW: Reirradiation of primary brain tumours: survival, clinical response and prognostic factors. Radiother Oncol 2001;59:127.
19. Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, McKenna WG, Byhardt R: Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997;37:745.
20. Sperduto P W, Berkey B, Gaspar LE, Mehta M, Curran W: A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. Int J Radiat Oncol Biol Phys 2008;70:510.
21. Golden DW, Lamborn KR, McDermott MW, Kunwar S, Wara WM, Nakamura JL, Sneed PK: Prognostic factors and grading systems for overall survival in patients treated with radiosurgery for brain metastases: variation by primary site. J Neurosurg 2008;109(suppl):77.
22. Franzin A, Snider S, Picozzi P, Bolognesi A, Serra C, Vimercati A, Passarin O, Mortini P: Evaluation of different score index for predicting prognosis in gamma knife radiosurgical treatment for brain metastasis. Int J Radiat Oncol Biol Phys 2009;74: 707.
23. Cooper JS, Steinfeld AD, Lerch IA: Cerebral metastases: value of reirradiation in selected patients. Radiology 1990;174:883.
24. Wong W W, Schild SE, Sawyer TE, Shaw EG: Analysis of outcome in patients reirradiated for brain metastases. Int J Radiat Oncol Biol Phys 1996; 34:585.
25. Sadikov E, Bezjak A, Yi QL, Wells W, Dawson L, Millar BA, Laperriere N: Value of whole brain reirradiation for brain metastases-single centre experience. Clin Oncol (R Coll Radiol) 2007;19: 532.
26. Kwon KY, Kong DS, Lee JI, Nam DH, Park K, Kim JH: Outcome of repeated radiosurgery for recurrent metastatic brain tumors. Clin Neurol Neurosurg 2007;109:132.
27. Shuto T, Fujino H, Inomori S, Nagano H: Repeated Gamma Knife radiosurgery for multiple metastatic brain tumours. Acta Neurochir (Wien) 2004;146:989.
28. Welzel G, Fleckenstein K, Schaefer J, Hermann B, Kraus-Tiefenbacher U, Mai SK, Wenz F: Memory function before and after whole brain radiotherapy in patients with and without brain metastases. Int J Radiat Oncol Biol Phys 2008;72:1311.
29. Bhatnagar A, Heron DE, Kondziolka D, Lunsford LD, Flickinger JC: Analysis of repeat stereotactic radiosurgery for progressive primary and metastatic CNS tumors. Int J Radiat Oncol Biol Phys 2002;53: 527.
30. Yamanaka K, Iwai Y, Yasui T, Nakajima H, Komiyama M, Nishikawa M, Morikawa T, Kishi H: Gamma Knife radiosurgery for metastatic brain tumor: the usefulness of repeated Gamma Knife radiosurgery for recurrent cases. Stereotact Funct Neurosurg 1999;72(suppl 1):73.
31. Sanghera P, Lightstone AW, Hyde DE, Davey P: Case report: fractionated helical tomotherapy as an alternative to radiosurgery in patients unwilling to undergo additional radiosurgery for recurrent brain metastases. Br J Radiol 2010;83:e25.
32. Vecil GG, Suki D, Maldaun MV, Lang FF, Sawaya R: Resection of brain metastases previously treated with stereotactic radiosurgery. J Neurosurg 2005; 102:209.
33. Liu R, Wang X, Ma B, Yang K, Zhang Q, Tian J: Concomitant or adjuvant temozolomide with whole-brain irradiation for brain metastases: a meta-analysis. Anticancer Drugs 2010;21:120.
34. Fogh S, Machtay M, Werner-Wasik M, Curran WJ Jr, Bonanni R, Axelrod R, Andrews D, Dicker AP: Phase I trial using patupilone (epothilone B) and concurrent radiotherapy for central nervous system malignancies. Int J Radiat Oncol Biol Phys 2010;77: 1009.
35. Ammirati M, Cobbs CS, Linskey ME, Paleologos NA, Ryken TC, Burri SH, Asher AL, Loeffler JS, Robinson PD, Andrews DW, Gaspar LE, Kondziolka D, McDermott M, Mehta M P, Mikkelsen T, Olson JJ, Patchell RA, Kalkanis SN: The role of retreatment in the management of recurrent/progressive brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 2010;96: 85.
36. Maranzano E, Trippa F, Pacchiarini D, Chirico L, Basagni ML, Rossi R, Bellavita R, Schiavone C, Italiani M, Muti M: Re-irradiation of brain metastases and metastatic spinal cord compression: clinical practice suggestions. Tumori 2005;91:325.
37. Serizawa T, Saeki N, Higuchi Y, Ono J, Iuchi T, Nagano O, Yamaura A: Gamma knife surgery for brain metastases: indications for and limitations of a local treatment protocol. Acta Neurochir (Wien) 2005;147:721.